Downregulation or inactivation of WTAP or METTL3 during the initial stage, for example, may induce HCC, whereas upregulation or activation of WTAP or METTL3 during the later stage may accelerate HCC. This evidence concerns the gene METTL3 and hepatocellular carcinoma.